Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

Stewardship Health sale to private equity finalized for $245M
The physician group, once part of Steward Health Care, has been rebranded as Revere Medical.
Baxter producing IV solutions ahead of schedule at Asheville-area site
The company said its largest production line at its North Carolina plant is operational, accounting for 25% of total output. The site was damaged by flood waters from Hurricane Helene.
Bill introduced in Congress would raise physician reimbursement by 1.9%
The Medicare Patient Access and Practice Stabilization Act aims to change the annual Centers for Medicare and Medicaid Services physician fee schedule, which cut reimbursement by 2.8% for 2025.
Private equity owns 900 patient care centers in Philadelphia, report finds
Physical therapy practices in greater Philadelphia are of particular interest to private equity firms, with 271 locations owned by six companies. The report comes from the Private Equity Stakeholder Project (PESP).
Q&A: Medicaid evolving to meet the mental health and material needs of patients
The former Medicaid Director of Texas, Gary Jessee, tells HealthExec that state healthcare programs are raising the bar for care access and quality, even for patients covered by commercial plans.

PointRight Analytics Go Mobile

PointRight Inc., the leader in data-driven analytics for health care and insurance, announces the combined launch of its new iPad App, which now enables providers to have mobile and flexible access to all of PointRight's data analytics services and reports via their iPad. The iPad app is available for free download via the Apple® iTunes® Store.

April 2, 2013

Around the web

Cardiovascular Business

Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more.

Cardiovascular Business

Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business

FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country.

Economics

Stewardship Health sale to private equity finalized for $245M

Baxter producing IV solutions ahead of schedule at Asheville-area site

Bill introduced in Congress would raise physician reimbursement by 1.9%

Private equity owns 900 patient care centers in Philadelphia, report finds

Q&A: Medicaid evolving to meet the mental health and material needs of patients

Around the web